Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval
Jan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreJan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreNEW YORK, Dec 22 (Reuters) - This year's steep decline in U.S. equities is juicing the ...
Read moreNov 8 (Reuters) - China's super-rich saw their wealth tumble by the most in over two ...
Read moreNEW YORK, Oct 14 (Reuters) - Gut-wrenching market volatility and attractive valuations are prompting some investors ...
Read moreOct 7 (Reuters) - The Biden administration on Friday published a sweeping set of export controls, ...
Read moreRegister now for FREE unlimited access to Reuters.comRegisterAll eyes on August CPI report on TuesdayBristol Myers ...
Read moreA man wearing a face mask is seen inside the Shanghai Stock Exchange building, as the ...
Read moreA Toronto Stock Exchange sign adorns a doorway at the Exchange Tower building in Toronto, Ontario, ...
Read moreNov 30 (Reuters) - Below are company-related news and stories from French and Benelux media which ...
Read moreFinancials lead declines, real estate gainsOracle falls after report co in talks to buy CernerFedEx up ...
Read more© 2022 TheDailyStock.News